Anti-SYT10 monoclonal antibody

Anti-SYT10 antibody for FACS & in-vivo assay

Target products collectionGo to SYT10/SYT10 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP1738-Ab-1/ GM-Tg-hg-MP1738-Ab-2Anti-Human SYT10 monoclonal antibodyHuman
GM-Tg-rg-MP1738-Ab-1/ GM-Tg-rg-MP1738-Ab-2Anti-Rat SYT10 monoclonal antibodyRat
GM-Tg-mg-MP1738-Ab-1/ GM-Tg-mg-MP1738-Ab-2Anti-Mouse SYT10 monoclonal antibodyMouse
GM-Tg-cynog-MP1738-Ab-1/ GM-Tg-cynog-MP1738-Ab-2Anti-Cynomolgus/ Rhesus macaque SYT10 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP1738-Ab-1/ GM-Tg-felg-MP1738-Ab-2Anti-Feline SYT10 monoclonal antibodyFeline
GM-Tg-cang-MP1738-Ab-1/ GM-Tg-cang-MP1738-Ab-2Anti-Canine SYT10 monoclonal antibodyCanine
GM-Tg-bovg-MP1738-Ab-1/ GM-Tg-bovg-MP1738-Ab-2Anti-Bovine SYT10 monoclonal antibodyBovine
GM-Tg-equg-MP1738-Ab-1/ GM-Tg-equg-MP1738-Ab-2Anti-Equine SYT10 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP1738-Ab-1/ GM-Tg-hg-MP1738-Ab-2; GM-Tg-rg-MP1738-Ab-1/ GM-Tg-rg-MP1738-Ab-2;
GM-Tg-mg-MP1738-Ab-1/ GM-Tg-mg-MP1738-Ab-2; GM-Tg-cynog-MP1738-Ab-1/ GM-Tg-cynog-MP1738-Ab-2;
GM-Tg-felg-MP1738-Ab-1/ GM-Tg-felg-MP1738-Ab-2; GM-Tg-cang-MP1738-Ab-1/ GM-Tg-cang-MP1738-Ab-2;
GM-Tg-bovg-MP1738-Ab-1/ GM-Tg-bovg-MP1738-Ab-2; GM-Tg-equg-MP1738-Ab-1/ GM-Tg-equg-MP1738-Ab-2
Products NameAnti-SYT10 monoclonal antibody
Formatmab
Target NameSYT10
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-SYT10 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species SYT10 VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP1738
    Target NameSYT10
    Gene ID341359,54526,60567,697640,486612,101091953,537613,100070119
    Gene Symbol and SynonymsSYT10
    Uniprot AccessionQ6XYQ8,O08625
    Uniprot Entry NameSYT10_HUMAN,SYT10_RAT
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000110975
    Target ClassificationN/A

    The target: SYT10, gene name: SYT10, also named as . Predicted to enable several functions, including phospholipid binding activity; protein dimerization activity; and syntaxin binding activity. Predicted to be involved in several processes, including cellular response to calcium ion; regulation of secretion by cell; and sensory perception of smell. Predicted to be located in synapse and transport vesicle membrane. Predicted to be integral component of membrane. Predicted to be active in exocytic vesicle and plasma membrane. .



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.